In tumor lysates from ebselen oxide‐treated animals, HER2 activation was decreased by 30% compared with vehicle‐treated animals (Fig. 5J,K) accompanied by a 50% inhibition of Akt activation and 45% inhibition of ERK activation (Fig. 5J,K). The gene discussed is ERBB2; the disease is neoplasm.